Stay updated on Ipilimumab Nivolumab in PD-1-resistant Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab Nivolumab in PD-1-resistant Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab Nivolumab in PD-1-resistant Lung Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4 and removed Revision: v3.3.3 from the page. This is an administrative update to the version history and does not affect trial data, eligibility criteria, or study details.
    Difference
    0.1%
    Check dated 2026-01-14T03:53:37.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    A new Locations section appears with Connecticut listed, replacing the older Connecticut Locations header; the HHS Vulnerability Disclosure footer link and the older revision label were removed.
    Difference
    0.2%
    Check dated 2025-12-23T21:44:21.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision: v3.3.2 added and Revision: v3.2.0 removed; this is a minor metadata update with no changes to study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:28:57.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The site-wide notification about government funding and NIH operation status has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:12:14.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    - The update seems limited to dates and minor formatting; core study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T21:16:54.000Z thumbnail image
  8. Check
    105 days ago
    Change Detected
    Summary
    The page now includes a government-operating-status notice and a v3.2.0 revision, replacing the prior v3.1.0 revision.
    Difference
    2%
    Check dated 2025-10-06T05:58:01.000Z thumbnail image

Stay in the know with updates to Ipilimumab Nivolumab in PD-1-resistant Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab in PD-1-resistant Lung Cancer Clinical Trial page.